Evidence for the involvement of infectious agents in the pathogenesis of Crohn"s disease

被引:77
作者
De Hertogh, Gert [2 ]
Aerssens, Jeroen [3 ]
Geboes, Karen P. [1 ]
Geboes, Karel [2 ]
机构
[1] Katholieke Univ Leuven Hosp, Dept Gastroenterol, B-3000 Louvain, Belgium
[2] Katholieke Univ Leuven Hosp, Dept Pathol, B-3000 Louvain, Belgium
[3] Tibotec bvba, B-2800 Mechelen, Belgium
关键词
Crohn's disease; etiology; microbiology;
D O I
10.3748/wjg.14.845
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Many advances have been made in the understanding of Crohn's disease (CD) pathogenesis during the last decade. CD is currently seen as a predominantly T-lymphocyte-driven disease characterized by the presence of a complex cocktail of interacting cytokines, chemokines and other mediators produced by a variety of cell types. Prevailing theories of CD pathogenesis suggest that patients' T-lymphocytes are inappropriately activated in the setting of an immune imbalance, which is itself caused by an unfortunate confluence of genetic and environmental factors. The T-cell response then leads to the chronic inflammation characteristic for the disease. Various environmental factors may play a role in the development of CD, but microbes are most consistently implied. This theory is based on epidemiological, clinicopathological, genetic and experimental evidence. Despite the abundance of arguments for the implication of bacteria in the aetiopathogenesis of CD, the precise role of bacteria in this disease still remains elusive. Three not necessarily mutually exclusive theories have been proposed: (1) an unidentified persistent pathogen; (2) an abnormally permeable mucosal barrier leading to excessive bacterial translocation; and (3) a breakdown in the balance between putative "protective" versus "harmful" intestinal bacteria ("dysbiosis"). At present, one cannot exclude with certainty any of these three proposed hypotheses; they may all apply to CD to a certain extent. (C) 2008 WJG. All rights reserved.
引用
收藏
页码:845 / 852
页数:8
相关论文
共 127 条
[1]
INCIDENCE OF PATHOGENIC BACTERIA FROM MESENTERIC LYMPH-NODES AND ILEAL SEROSA DURING CROHNS-DISEASE SURGERY [J].
AMBROSE, NS ;
JOHNSON, M ;
BURDON, DW ;
KEIGHLEY, MRB .
BRITISH JOURNAL OF SURGERY, 1984, 71 (08) :623-625
[2]
ANTIBIOTIC-THERAPY FOR TREATMENT IN RELAPSE OF INTESTINAL CROHNS-DISEASE - A PROSPECTIVE RANDOMIZED STUDY [J].
AMBROSE, NS ;
ALLAN, RN ;
KEIGHLEY, MRB ;
BURDON, DW ;
YOUNGS, D ;
BARNES, P ;
LENNARDJONES, JE .
DISEASES OF THE COLON & RECTUM, 1985, 28 (02) :81-85
[3]
Appendectomy is followed by increased risk of Crohn's disease [J].
Andersson, RE ;
Olaison, G ;
Tysk, C ;
Ekbom, A .
GASTROENTEROLOGY, 2003, 124 (01) :40-46
[4]
Preliminary study of ciprofloxacin in active Crohn's disease [J].
Arnold, GL ;
Beaves, MR ;
Pryjdun, VO ;
Mook, WJ .
INFLAMMATORY BOWEL DISEASES, 2002, 8 (01) :10-15
[5]
High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn's disease [J].
Autschbach, F ;
Eisold, S ;
Hinz, U ;
Zinser, S ;
Linnebacher, M ;
Giese, T ;
Löffler, T ;
Büchler, MW ;
Schmidt, J .
GUT, 2005, 54 (07) :944-949
[6]
Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria [J].
Ayabe, T ;
Satchell, DP ;
Wilson, CL ;
Parks, WC ;
Selsted, ME ;
Ouellette, AJ .
NATURE IMMUNOLOGY, 2000, 1 (02) :113-118
[7]
Nipple valve anastomosis for preventing recurrence of Crohn disease in the neoterminal ileum after ileocolic resection - A prospective pilot study [J].
Bakkevold, KE .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2000, 35 (03) :293-299
[8]
Baliellas C, 1996, REV ESP ENFERM DIG, V88, P419
[9]
BELSHEIM MR, 1983, GASTROENTEROLOGY, V85, P364
[10]
BLASER MJ, 1984, GASTROENTEROLOGY, V86, P33